论文部分内容阅读
目的观察养正消积胶囊治疗原发性肝癌的临床疗效。方法将80例原发性肝癌患者随机分为两组,各40例;对照组给予常规介入化疗,治疗组在常规介入化疗基础上结合口服养正消积胶囊,疗程4周。观察两组治疗前后瘤体疗效、Karnofsky评分和甲胎蛋白水平变化。结果治疗后,治疗组实体瘤疗效和生存质量(Karnofsky评分)疗效均优于对照组(P<0.05,P<0.01),两组甲胎蛋白水平均明显降低(P<0.05)。结论养正消积胶囊有助于缩小原发性肝癌瘤体,提高生存质量。
Objective To observe the clinical efficacy of Yangzheng Xiaoji Capsule in the treatment of primary liver cancer. Methods Eighty patients with primary hepatocellular carcinoma were randomly divided into two groups, 40 cases in each group. The control group was given conventional interventional chemotherapy. The treatment group was given oral administration of Zhengzheng Xiaoji Capsule on the basis of conventional interventional chemotherapy for 4 weeks. The curative effect, Karnofsky score and alpha-fetoprotein level of the two groups before and after treatment were observed. Results After treatment, the curative effect of solid tumor and the quality of life (Karnofsky score) in the treatment group were better than those in the control group (P <0.05, P <0.01). The levels of alpha-fetoprotein in both groups were significantly decreased (P <0.05). Conclusion Yangzheng Xiaoji capsule can help to reduce the primary liver cancer and improve the quality of life.